Top

Reactions Weekly

Published in:

01-01-2016 | Case report

Dihydrocodeine/methylephedrine-hydrochloride/muramidase/paracetamol

Autoimmune hepatitis: case report

Published in: Reactions Weekly | Issue 1/2016

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

…

Takeda K, et al. A case of over-the-counter, drug-induced autoimmune hepatitis: immunohistochemical and electron microscopic studies. American Journal of Gastroenterology 110 (Suppl. 1): S310, Oct 2015. Available from: URL: http://doi.org/10.1038/ajg.2015.270 [abstract] - Japan

Title: Dihydrocodeine/methylephedrine-hydrochloride/muramidase/paracetamol
Autoimmune hepatitis: case report
Publication date: 01-01-2016
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2016
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-14147-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dihydrocodeine/methylephedrine-hydrochloride/muramidase/paracetamol

Autoimmune hepatitis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Enoxaparin sodium

Abatacept

Pergolide

Sorafenib

Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat

Adalimumab